nach oben

Annals of Nuclear Medicine

Erschienen in:

25.05.2020 | Original Article

Detectable size of melanoma metastases to brain on PET/CT

verfasst von: Jorge D. Oldan, Samuel A. Glaubiger, Amir H. Khandani, Valerie L. Jewells

Erschienen in: Annals of Nuclear Medicine | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

We aimed to determine at what size melanoma metastases become detectable by PET/CT.

Methods

We reviewed a total of 293 whole-body PET/CT studies performed on 212 patients for staging of melanoma where there was an MRI within a month of the PET/CT. MR and PET/CT were reviewed independently by separate readers.

Results

PET/CT revealed an overall incidental true-positive rate of 1% on a per-patient basis, consistent with other studies, with ‘hot’ lesions (more avid than brain parenchyma) visible at smaller sizes than ‘cold’ lesions.

Conclusions

PET/CT can detect metastatic melanoma lesions over about 2 cm in size, with hot lesions generally visible at smaller sizes.

Bochev P, Klisarova A, Kaprelyan A, Chaushev B, Dancheva Z. Brain metastases detectability of routine whole body (18)F-FDG PET and low dose CT scanning in 2502 asymptomatic patients with solid extracranial tumors. Hell J Nucl Med. 2012;15(2):125–9.PubMed

Manohar K, Bhattacharya A, Mittal BR. Low positive yield from routine inclusion of the brain in whole-body 18F-FDG PET/CT imaging for noncerebral malignancies: results from a large population study. Nucl Med Commun. 2013;34(6):540–3.CrossRef

Salvatore B, Caprio MG, Fonti R, D'Amico D, Fraioli F, Salvatore M, et al. Is 2-deoxy-2-[(18)F]fluoro-D-glucose PET/CT acquisition from the upper thigh to the vertex of skull useful in oncological patients? Transl Med UniSa. 2015;11:34–8.PubMed

Tasdemir B, Dostbil Z, Inal A, Unal K, Yildirim S, Simsek FS. Evaluation of clinical contributions provided by addition of the brain, calvarium, and scalp to the limited whole body imaging area in FDG-PET/CT tumor imaging. Biomed Res Int. 2014;2014:129683.CrossRef

Webb HR, Latifi HR, Griffeth LK. Utility of whole-body (head-to-toe) PET/CT in the evaluation of melanoma and sarcoma patients. Nucl Med Commun. 2018;39(1):68–73.CrossRef

Niederkohr RD, Rosenberg J, Shabo G, Quon A. Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma. Nucl Med Commun. 2007;28(9):688–95.CrossRef

Sinclair G, Benmakhlouf H, Martin H, Brigui M, Maeurer M, Dodoo E. The role of radiosurgery in the acute management of fourth ventricle compression due to brain metastases. Surg Neurol Int. 2018;9:112.CrossRef

Horky LL, Hsiao EM, Weiss SE, Drappatz J, Gerbaudo VH. Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis. J Neurooncol. 2011;103(1):137–46.CrossRef

Titel: Detectable size of melanoma metastases to brain on PET/CT
verfasst von: Jorge D. Oldan
Samuel A. Glaubiger
Amir H. Khandani
Valerie L. Jewells
Publikationsdatum: 25.05.2020
Verlag: Springer Singapore
Erschienen in: Annals of Nuclear Medicine / Ausgabe 8/2020
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-020-01481-8

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2020

Diagnostic performance of whole-body bone scintigraphy in combination with SPECT/CT for detection of bone metastases

Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acids

Assessing the effects of body weight on subchondral bone formation with quantitative 18F-sodium fluoride PET

Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound

Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT

Brain 18F-FDG PET analysis via interval-valued reconstruction: proof of concept for Alzheimer’s disease diagnosis